Overall ORKA gets a fundamental rating of 3 out of 10. We evaluated ORKA against 525 industry peers in the Biotechnology industry. While ORKA has a great health rating, there are worries on its profitability. ORKA has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

ORKA had negative earnings in the past year.
ORKA had a negative operating cash flow in the past year.
ORKA had negative earnings in each of the past 5 years.
ORKA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of ORKA (-19.96%) is better than 76.57% of its industry peers.
ORKA has a better Return On Equity (-20.88%) than 82.86% of its industry peers.

		Industry Rank	Sector Rank
ROA	-19.96%
ROE	-20.88%
ROIC	N/A

ROA(3y)-19.43%

ROA(5y)-22.56%

ROE(3y)-20.05%

ROE(5y)-23.79%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ORKA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ORKA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ORKA has more shares outstanding
ORKA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

ORKA has an Altman-Z score of 44.72. This indicates that ORKA is financially healthy and has little risk of bankruptcy at the moment.
ORKA has a Altman-Z score of 44.72. This is amongst the best in the industry. ORKA outperforms 95.43% of its industry peers.
There is no outstanding debt for ORKA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	44.72

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

ORKA has a Current Ratio of 16.94. This indicates that ORKA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 16.94, ORKA belongs to the top of the industry, outperforming 93.71% of the companies in the same industry.
A Quick Ratio of 16.94 indicates that ORKA has no problem at all paying its short term obligations.
The Quick ratio of ORKA (16.94) is better than 93.71% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	16.94
Quick Ratio	16.94

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.48% over the past year.

EPS 1Y (TTM)66.48%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%62.33%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ORKA will show a decrease in Earnings Per Share. The EPS will decrease by -2.48% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y36.65%

EPS Next 2Y11.73%

EPS Next 3Y5.34%

EPS Next 5Y-2.48%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ORKA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ORKA. No positive earnings are expected for the next year.